CFTR and cystic fibrosis: Recently, Birimberg-Schwartz and colleagues [27], through a direct comparison of electrophysiological measurement of the intestine and nasal cells, further confirmed the suitability of 2D intestinal monolayers for theratyping applications in CF showing a larger measurable CFTR functional range in response to agonists in comparison to nasal cells.